|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21.01.26 - 01:33
|
Trump Says ′Agitators′ In Minnesota Church Should Be Jailed, Wants Broader Investigation (ZeroHedge)
|
|
|
Trump Says 'Agitators' In Minnesota Church Should Be Jailed, Wants Broader Investigation
Authored by Jack Phillips via The Epoch Times (emphasis ours),
President Donald Trump said that people who stormed a Minneapolis church over the past weekend should be jailed, while calling on the Department of Justice (DOJ) to investigate two local Democratic politicians.
President Donald Trump speaks during the "Great, Historic Investment in Rural Health Roundtable" in the East Room of the White House on Jan. 16, 2026. Madalina Kilroy/The Epoch Times
“Just watched footage of the Church Raid in Minnesota by the agitators and insurrectionists. These people are professionals! No person acts the way they act,” Trump said in a Truth Social post on early Tuesday.
The individuals who appeared at the church “are highly trained to scream, rant, and rave, like lunatics, in a certain manner, just like they are doing. They are troublemakers who should be thrown in jail, or thrown out of the Country...
|
|
|
|
|
|
|
|
|
21.01.26 - 01:06
|
Trump has growing stranglehold over EU and UK energy supply, study shows (The Guardian)
|
|
|
European countries now reliant on US liquified natural gas shipments, creating risk of higher bills amid recent tensionsDonald Trump has a stranglehold over EU and UK energy supply as a result of Europe swapping its dependency on Russia for reliance on the US, analysis has shown.In part due to the war in Ukraine and the imposition of sanctions on Russian pipeline gas, European countries have become dependent on shipments of US liquified natural gas (LNG), according to a paper co-authored by the Clingendael Institute, in The Hague, the Ecologic Institute, in Berlin, and the Norwegian Institute of International Affairs. Continue reading......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21.01.26 - 00:36
|
Harbour BioMed stake in US drug firm Spruce shows Chinese firms′ growing clout, analysts say (SCMP)
|
|
|
Shanghai-based Harbour BioMed's acquisition of a stake in US-based Spruce Biosciences is the latest example of China's novel drug developers progressing from one-time licensing deals into long-lasting equity partnerships with overseas partners.
The deal, detailed in a Hong Kong stock exchange filing on Monday, also showed Chinese firms' growing clout on the global pharmaceutical stage, analysts said.
“The coming years will see more Chinese biotech firms engaging in equity investments and joint......
|
|